Table 1 Hematologic parameters of HIV-positive patients, HIV-positive patients on antiretroviral drugs and HIV-negative subjects

2418.20 ± 376.35^a

4681.80 ± 485.42^b

6081.80 ± 925.01^c

2300.00 ± 331.66^a

4666.70 ± 512.18^b

6333.30 ± 1085.4^c

2225.00 ± 298.18^a

4500.00 ± 431.38^b

6588.90 ± 774.51^c

2360.00 ± 450.19^a

4710.00 ± 387.15^b

6225.00 ± 775.89^c

2475.00 ± 320.16^a

4475.00 ± 250.00^b

6500.00 ± 1050.9^c

75.00 ± 1.00^c

65.09 ± 2.30^b,d

61.91 ± 3.33^a,d,e

75.29 ± 1.15^c

65.81 ± 13.20^b

62.40 ± 3.48^a,d,e

74.96 ± 1.27^c

66.00 ± 1.32^b

62.06 ± 3.33^a,e

75.00 ± 1.06^c

65.80 ± 1.99^b

61.81 ± 2.32^a,e

75.50 ± 1.00^c

66.00 ± 1.41^b,e

63.40 ± 2.50^a,b

12.36 ± 0.81^a

26.64 ± 2.20^b,d

29.82 ± 3.40^c

12.00 ± 0.89^a

26.48 ± 2.21^b

31.13 ± 3.00^c

12.33 ± 0.92^a

26.21 ± 1.02^b

29.22 ± 2.63^c,d

12.30 ± 0.95^a

26.70 ± 2.41^b,d

29.88 ± 2.16^c

11.50 ± 1.73^a

27.75 ± 1.29^b,c

28.40 ± 2.80^b,c

11.27 ± 2.61^b

4.82 ± 0.75^a

4.91 ± 1.04^a

10.52 ± 0.68^b

4.43 ± 1.03^a

4.53 ± 1.41^a

10.50 ± 0.59^b

4.58 ± 1.02^a

5.39 ± 1.20^a

10.20 ± 1.14^b

3.80 ± 1.03^a

5.00 ± 1.59^a

10.75 ± 0.96^b

3.75 ± 0.96^a

4.50 ± 1.08^a

2.09 ± 0.54^a

3.09 ± 1.04^a

3.18 ± 1.25^a

2.05 ± 0.67^a

3.05 ± 1.12^a

2.40 ± 1.55^a

2.13 ± 0.54^a

2.96 ± 0.86^a

3.06 ± 1.51^a

2.20 ± 0.79^a

3.20 ± 0.92^a

3.00 ± 1.03^a

2.00 ± 0.82^a

2.25 ± 1.26^a

3.30 ± 0.82^a

0.09 ± 0.30^a

0.36 ± 0.50^a

0.27 ± 0.47^a

0.10 ± 0.30^a

0.24 ± 0.45^a

0.20 ± 0.41^a

0.13 ± 0.34^a

0.25 ± 0.44^a

0.28 ± 0.46^a

0.30 ± 0.50^a

0.50 ± 0.53^a

0.31 ± 0.48^a

0.25 ± 0.50^a

0.25 ± 0.50^a

0.40 ± 0.52^a